Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis

Glycobiology

Volumn 17, Issue 5, 2007, Pages 492-503

  Pakula, Rachel ^b   Melchior, Aurélie ^b   Denys, Agnès ^b   Vanpouille, Christophe ^a   Mazurier, Joël ^b   Allain, Fabrice ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

CD147; Cyclophilin B; Heparan sulphate; Syndecan

Indexed keywords

CD147 ANTIGEN; CD44V ANTIGEN; CD44V3 ANTIGEN; CORE PROTEIN; CYCLOPHILIN B; HEPARAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P44; PROTEOGLYCAN; SMALL INTERFERING RNA; SYNDECAN 1; SYNDECAN 2; SYNDECAN 4; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS; CHROMOGRANINS; CYCLOPHILINS; ENZYME ACTIVATION; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INFLAMMATION MEDIATORS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MODELS, IMMUNOLOGICAL; PEPTIDYLPROLYL ISOMERASE; SYNDECAN-1;

EID: 34447295921     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwm009     Document Type: Article

References (55)

1. Allain F, Vanpouille C, Carpentier M, Slomianny M-C, Durieux S, Spik G. 2002. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc Natl Acad Sci USA 99:2714-2719.
2. Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, Bukrinsky MI, and Constant SI. 2005. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol. 175:517-522.
3. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, ZakoM. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 68:729-777.
4. Billich A, Winkler G, Aschauer H, Rot A, Peichl P. 1997. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med. 185:975-980.
5. Brazin KN, Mallis RJ, Fulton DB, Andreotti AH. 2002. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci USA. 99:1899-1904.
6. Carpentier M, Allain F, Haendler B, Denys A, Mariller C, Benaïssa M, Spik G. 1999. Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. J Biol Chem. 274:10990-10998.
7. Carpentier M, Allain F, Slomianny MC, Durieux S, Vanpouille C, Haendler B, Spik G. 2002. Receptor type I and type II binding regions and the peptidylprolyl isomerase site of cyclophilin B are required for enhancement of T-lymphocyte adhesion to fibronectin. Biochemistry. 41:5222-5229.
8. Charnaux N, Brule S, Hamon M, Chaigneau T, Saffar L, Prost C, Lievre N, Gattegno L. 2005. Syndecan-4 is a signaling molecule for stromal cellderived factor-1 (SDF-1)/CXCL12. FEBS Lett. 272:1937-1951.
9. Delehedde M, Allain F, Payne SJ, Borgo R,Vanpouille C, Fernig DG, Deudon E. 2002. Proteoglycans in inflammation. Curr Med Chem. 1:89-102.
10. De Ceuninck F, Allain F, Caliez A, Spik G, Vanhoutte PM. 2003. High binding capacity of cyclophilin B to chondorocyte heparan sulfate proteoglycans, and its release from the cell surface by metalloproteinases. Arthritis Rheum. 48:2197-2206.
11. Deng X, Bellis S, Yan Z, Friedman E. 1999. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF). beta1 in cells with nonfunctional TGF-beta receptor type III. Cell Growth Differ. 10:11-18.
12. Denys A, Allain F, Foxwel B, Spik G. 1997. Distribution of cyclophilin B-binding sites in the subsets of human peripherical blood lymphocytes. Immunology. 91:609-617.
13. Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST. 2002. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood. 99:1405-1410.
14. Drzeniek Z, Siebertz B, Stöcker G, Just U, Ostertag W, Greiling H, Haubeck H-D. 1997. Proteoglycan synthesis in haematopoietic cells: isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5. Biochem J. 327:473-480.
15. Endrich MM, Gehring H. 1998. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. Eur J Biochem. 252:441-446.
16. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 337:476-478.
17. Galat A. 1999. Variations of sequences and amino acid compositions of proteins that sustain their biological functions: An analysis of the cyclophilin family of proteins. Arch Biochem Biophys. 371:149-162.
18. Gonzalez-Cuadrado S, Bustos C, Ruiz-Ortega M, Ortiz A, Guijarro C, Plaza JJ, Egido J. 1996. Expression of leucocyte chemoattractants by interstitial renal fibroblasts: Up-regulation by drugs associated with interstitial fibrosis. Clin Exp Immunol. 106:518-522.
19. Guo H, Zucker S, Gordon MK, Toole BP, Biwas C. 1997. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem. 272:24-27.
20. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. 1984. Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science. 226:544-547.
21. Ilangumaran S, Borisch B, Hoessli DC. 1999. Signal transduction via CD44: Role of plasma membrane microdomains. Leuk Lymphoma. 35:455-469.
22. Itano N, Oguri K, Nagayasu N, Kusano Y, Nakanishi H, David G, Okayama M. 1996. Phosphorylation of a membrane-intercalated proteoglycan, syndecan-2, expressed in a stroma-inducing clone from a mouse Lewis lung carcinoma. Biochem J. 315:925-930.
23. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle NP. 1995. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol. 128:673-685.
24. Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC. 2000. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 87:789-796.
25. Jones M, Tussey L, Athanasou N, Jackson DG. 2000. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem. 17:7964-74.
26. Kaneider NC, Reinisch CM, Dunzendorfer S, Romisch J, Wiederman CJ. 2002. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J Cell Sci. 115:227-236.
27. Kim H, Kim W-J, Jeon S-T, Koh E-M, Cha H-S, Ahn K-S, Lee W-H. 2005. Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages. Clin Immunol. 116:217-224.
28. Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M. 2000. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: Structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res. 256:434-444.
29. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 38:12959-12968.
30. Modrowski D, Basle M, Lomri A, Marie PJ. 2000. Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colonystimulating factor in osteoblasts. J Biol Chem. 275:9178-9185.
31. Mosheimer BA, Kaneider NC, Feistritzer C, Djanani AM, Sturn DH, Patsch JR, Wiedermann CJ. 2005. Syndecan-1 is involved in osteoprotegerininduced chemotaxis in human peripheral blood monocytes. J Clin Endocrinol Metab. 90:2964-2971.
32. Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M. 2002. The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones. Biochem J. 363:201-209.
33. Pushkarsky T, Zybarth G, Dubrovsky L, Yurchenko V, Tang H, Guo H, Toole B, Sherry B, Bukrinsky M. 2001. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci USA. 98: 6360-6365.
34. Rapraeger AC, Ott VL. 1998. Molecular interactions of the syndecan core proteins. Curr Opin Cell Biol. 10:620-628.
35. Roscic-Mrkic B, Fischer M, Leeman C, Manrique A, Gordon CJ, Moore JP, Proudfoot AE, Trkola A. 2003. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood. 102:1169-1177.
36. Saphire AC, Bobardt MD, Gallay PA. 1999. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18:6771-6785.
37. Saphire AC, Bobardt MD, Zhang Z, David G, Gallay PA. 2001. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol. 75:9187-9200.
38. Schreiber SL. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 251:283-287.
39. Selleck SB. 2000. Proteoglycans and pattern formation: Sugar biochemistry meets developmental genetics. Trends Genet. 16:206-212.
40. Sherry B, Yarlet N, Strup A, Cerami A. 1992. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA. 89:3511-3515.
41. Spik G, Haendler B, Delmas O, Mariller C, Chamoux M, Maes P, Tartar A, Montreuil J, Stedman K, Kocher HP et al., 1991. A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem. 266:10735-10738.
42. Sun J, Hemler ME. 2001. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res. 61:2276-2281.
43. Takahashi N, Hayano T, Suzuki M. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 337:473-475.
44. Tanaka Y, Adams DH, Shaw S. 1993. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14: 111-115.
45. Tegeder I, Schumacher A, John S, Geiger H, Geisslinger G, Bang H, Brune K. 1997. Elevated serum cyclophilins levels in patients with severe sepsis. J Clinical Immunol. 17:380-386.
46. Toole BP. 2003. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol. 54:371-389.
47. Vanpouille C, Denys A, Carpentier M, Pakula R, Mazurier J, Allain F. 2004. Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and heparan sulfates. Biochem J. 382:733-740.
48. Vey E, Zhang JH, Dayer JM. 1992. IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, responsiveness to contact with activated T cells. J Immunol. 15:2040-2046.
49. Volk R, Schwartz JJ, Li J, Rosenberg RD, Simons M. 1999. The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction. J Biol Chem. 274:24417-24424.
50. Woods A, Couchman JR. 2001. Syndecan-4 and focal adhesion function. Curr Opin Cell Biol. 13:578-583.
51. Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle CR. 1992. Leukocyte chemotactic activity of cyclophilin. J Biol Chem. 267: 11968-11971.
52. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:841-848.
53. Yurchenko V, O'Connor M, DaiWW, Guo H, Toole B, Sherry B, BukrinskyM. 2001. CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun. 288:786-788.
54. Yurchenko V, Zybarth G, O'Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung HC, Toole B, Gallay P, Sherry B, Bukrinsky M. 2002. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem. 277:22959-22965.
55. Zhu P, Ding J, Zhou J, Dong WJ, Fan CM, Chen ZN. 2005. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: Its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res Ther. 7, 1023-1033.